Spironolactone and Prevention of Calcineurin Inhibitor Toxicity in Kidney Transplant Recipients

Update Il y a 4 ans
Reference: NCT01021943

Woman and Man

  • | Country :
  • Mexico
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The main objective of this study is to assess the effect of spironolactone on interstitial fibrosis in kidney transplant recipients receiving calcineurin inhibitors


Inclusion criteria

  • Kidney transplant

Links